Abstract:Objective To analyze the value of fecal DNA methylation detected by methylation microarrays in colorectal cancer screening among ethnic minority populations in Hainan.Methods A total of 102 ethnic minority individuals at a high risk for colorectal cancer in Hainan Provincial People's Hospital from June 2020 to June 2022 were selected, and another 30 healthy volunteers were recruited as the control group. The forepart feces samples of all patients excreted naturally or facilitated with laxatives before colonoscopy were collected for DNA methylation profiling via microarrays. According to the pathological findings, 102 patients were divided into colorectal cancer group, adenoma group and hyperplastic polyp group, and the methylation levels of VAV3, IKZF1 and RIMS1 genes in feces samples of the four groups were compared. Taking the pathological findings as the gold standard, we evaluated the diagnostic efficacy of the combined detection of fecal VAV3, IKZF1 and RIMS1 genes for colorectal cancer and adenoma.Results The methylation levels of fecal VAV3, IKZF1 and RIMS1 genes and their combination in the colorectal cancer group were higher than those in the adenoma group, hyperplastic polyp group and control group (P < 0.05). There was no significant difference in the methylation levels of fecal VAV3, IKZF1 and RIMS1 genes and their combination between adenoma group and hyperplastic polyp group (P > 0.05). The combined detection of fecal VAV3, IKZF1 and RIMS1 genes yielded the highest specificity, sensitivity, negative predictive value, positive predictive value, and accuracy for diagnosing colorectal cancer and adenoma, with them being 100.00%, 92.31%, 92.59%, 100.00%, and 96.08% for colorectal cancer, and 97.30%, 71.43%, 90.00%, 90.91%, and 90.20% for adenoma, respectively.Conclusions The DNA methylation profiling via microarrays indicates that the VAV3, IKZF1 and RIMS1 genes in the feces of colorectal cancer patients of ethnic minority in Hainan are highly methylated. The combined detection of the three genes can improve the diagnostic efficacy of colorectal cancer and adenoma.